Enterome Bioscience deal allows BMS to apply gut microbiome lens across immuno-oncology
By Cormac Sheridan
Wednesday, November 16, 2016
DUBLIN – The still-tentative dalliance between immuno-oncology and gut microbiome research could blossom into a full-on romance, as BMS and Enterome Bioscience SA entered a broadly based pact.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.